You are here

Leqembi

Lilly Alzheimer's med glides out of Leqembi's slipstream with FDA adcomm request

Fierce Biotech

Wed, 04/17/24 - 09:58 pm

Alzheimer's disease

Biogen and Eisai Fall Behind on Leqembi’s Subcutaneous BLA for Alzheimer’s

BioSpace

Mon, 04/1/24 - 12:14 pm

Alzheimer's disease

Eisai and Biogen facing delay to Leqembi in Europe

Pharmaphorum

Mon, 03/25/24 - 11:22 am

Alzheimer's disease

Eisai backs Leqembi’s Japan rollout with insurance policy

Pharmaphorum

Thu, 03/21/24 - 11:19 am

Tau, anti-inflammation and orals form Biogen's future Alzheimer's pipeline

Fierce Biotech

Thu, 03/7/24 - 11:38 am

Alzheimer's disease

anti-tau antibodies

anti-inflammatory

Japan's Eisai says US introduction of Alzheimer's drug Leqembi slower than expected

Reuters

Thu, 03/7/24 - 11:07 am

Alzheimer's disease

Biogen relying on success of Leqembi following discontinuation of Aduhelm

Biopharma Reporter

Mon, 03/4/24 - 11:19 am

Aduhelm. Alzheimer's disease

Biogen has a fuzzy line of sight on prized Alzheimer’s drug

BioPharma Dive

Tue, 02/13/24 - 11:16 pm

Alzheimer's disease

Eisai, Biogen likely to miss early launch goal for Alzheimer's drug Leqembi

Fierce Pharma

Wed, 02/7/24 - 11:33 am

Alzheimer's disease

Biogen abandons Aduhelm efforts, focuses on Eisai-partnered Leqembi and pipeline drugs

Fierce Pharma

Wed, 01/31/24 - 11:50 am

Alzheimer's disease

EU regulators to consult advisers in review of Eisai Alzheimer’s drug

BioPharma Dive

Thu, 01/11/24 - 08:40 pm

Alzheimer's disease

Biogen CEO sees progress in launch of Alzheimer’s drug Leqembi

BioPharma Dive

Mon, 01/8/24 - 10:22 pm

Chris Viehbacher

Alzheimer's disease

As Biogen's sales flatline, CEO Chris Viehbacher touts progress on Leqembi, Skyclarys and other launches

Fierce Pharma

Wed, 11/8/23 - 12:10 pm

Chris Viehbacher

Biogen's M&A, Alzheimer's drug launch costs spark profit forecast cut

Reuters

Wed, 11/8/23 - 11:35 am

Alzheimer's disease

Eisai expects Alzheimer's drug to rake in revenue of $66.5 million by March

Reuters

Tue, 11/7/23 - 09:57 am

Alzheimer's disease

Eisai says new data could support more convenient form of Alzheimer’s drug Leqembi

BioPharma Dive

Wed, 10/25/23 - 10:42 pm

Alzheimer's disease

As 'harvest time' arrives for Alzheimer's, neuroscientist reflects on next steps for drug development

Fierce Biotech

Mon, 10/16/23 - 10:12 am

Alzheimer's disease

Japan approves Alzheimer's treatment Leqembi by Eisai and Biogen

Reuters

Tue, 09/26/23 - 10:23 am

Alzheimer's disease

The Alzheimer’s Treatment Landscape: Leqembi vs. Donanemab

BioSpace

Mon, 09/11/23 - 12:34 pm

Alzheimer's disease

New Alzheimer’s drug raises hopes — along with questions

Medical Marketing and Media

Mon, 08/14/23 - 06:54 pm

Alzheimer's disease

Pages